These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 17192946)

  • 1. Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hr after tracer injection in sentinel lymph node biopsy in breast cancer patients.
    Doting MH; Stiekema HM; de Vries J; Lemstra C; Hoekstra HJ; Vrieling M; Rietman L; Jager PL
    J Surg Oncol; 2007 May; 95(6):469-75. PubMed ID: 17192946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.
    Kern KA; Rosenberg RJ
    J Am Coll Surg; 2000 Nov; 191(5):479-89. PubMed ID: 11085727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.
    Haigh PI; Hansen NM; Giuliano AE; Edwards GK; Ye W; Glass EC
    J Nucl Med; 2000 Oct; 41(10):1682-8. PubMed ID: 11037998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
    Dunnwald LK; Mankoff DA; Byrd DR; Anderson BO; Moe RE; Yeung RS; Eary JF
    J Nucl Med Technol; 1999 Jun; 27(2):106-11. PubMed ID: 10353106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
    J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periareolar injection for localization of sentinel nodes in breast cancer patients.
    Ellis RL; Seifert PJ; Neal CE; Pavolka KR; Mann JL; Malafa MP; Wichterman KA; Ross DS; Dunnington GL
    Breast J; 2004; 10(2):94-100. PubMed ID: 15009034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
    Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
    Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P; Ibis E; Aras G; Cam R; Küçük NO
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
    Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
    Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer.
    Seok JW; Kim IJ; Heo YJ; Yang YJ; Choi YS; Kim BG; Park SJ
    Ann Nucl Med; 2009 Jul; 23(5):465-9. PubMed ID: 19452250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
    Rasgon BM
    Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
    Brouwer OR; Vermeeren L; van der Ploeg IM; Valdés Olmos RA; Loo CE; Pereira-Bouda LM; Smit F; Neijenhuis P; Vrouenraets BC; Sivro-Prndelj F; Jap-a-Joe SM; Borgstein PJ; Rutgers EJ; Oldenburg HS
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1137-43. PubMed ID: 22526968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of nonvisualized sentinel lymph nodes in unselected breast cancer patients during lymphoscintigraphy.
    Lo YF; Hsueh S; Ma SY; Chen SC; Chen MF
    Chang Gung Med J; 2005 Jun; 28(6):378-86. PubMed ID: 16124153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.